These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11757494)

  • 1. Summaries for patients. Cost-effectiveness of implantable defibrillators versus the drug amiodarone to prevent abnormal heart rhythms after heart attack.
    Ann Intern Med; 2001 Nov; 135(10):S-56. PubMed ID: 11757494
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
    Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
    Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone.
    Caro JJ; Ward A; Deniz HB; O'Brien JA; Ehreth JL
    Value Health; 2007; 10(1):13-22. PubMed ID: 17261112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are implantable cardioverter-defribrillators always superior to amiodarone?
    Doggrell SA
    Expert Opin Pharmacother; 2003 Nov; 4(11):2111-4. PubMed ID: 14596664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter regarding article by Bokhari et al, "Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)".
    Boriani G; Biffi M; Martignani C
    Circulation; 2005 Jan; 111(3):e26; author reply e26. PubMed ID: 15668348
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized clinical trials: how long should they last?
    Wellens HJ
    Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death.
    Owens DK; Sanders GD; Harris RA; McDonald KM; Heidenreich PA; Dembitzer AD; Hlatky MA
    Ann Intern Med; 1997 Jan; 126(1):1-12. PubMed ID: 8992917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction.
    Pedretti RF; Migliori GB; Mapelli V; Daniele G; Podrid PJ; Tramarin R
    J Am Coll Cardiol; 1998 Jun; 31(7):1481-9. PubMed ID: 9626823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction.
    Hlatky MA; Owens DK
    J Am Coll Cardiol; 1998 Jun; 31(7):1490-2. PubMed ID: 9626824
    [No Abstract]   [Full Text] [Related]  

  • 10. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
    Stevenson WG; Ridker PM
    JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are implantable cardioverter- defibrillators cost-effective?
    Naik AM; Peter CT
    Curr Cardiol Rep; 2000 Jul; 2(4):341-5. PubMed ID: 10953269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
    Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
    Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of cardiac arrest survivors: drugs or devices.
    Madan N; Saksena S; Prakash A; Mathew PP
    Indian Heart J; 1995; 47(4):387-93. PubMed ID: 8557286
    [No Abstract]   [Full Text] [Related]  

  • 15. Over-AVID subgroup analysis.
    Goldberger JJ; Parker MA; Kadish AH
    J Am Coll Cardiol; 2001 Nov; 38(5):1586-7. PubMed ID: 11691549
    [No Abstract]   [Full Text] [Related]  

  • 16. Amiodarone for the Prevention of Sudden Cardiac Death.
    Saguil A
    Am Fam Physician; 2016 Nov; 94(9):692-693. PubMed ID: 27929253
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lethal arrhythmia associated with heart failure].
    Shiga T; Hagiwara N; Kasanuki H
    Nihon Rinsho; 2007 May; 65 Suppl 5():364-8. PubMed ID: 17571407
    [No Abstract]   [Full Text] [Related]  

  • 18. Life-threatening arrhythmias and therapy.
    Myerburg RJ
    Resuscitation; 2000 Aug; 45(3):S1-2. PubMed ID: 10959026
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness of implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac death.
    Spath MA; O'Brien BJ
    Pharmacoeconomics; 2002; 20(11):727-38. PubMed ID: 12201792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination ICD and drug treatments-best options.
    Dorian P
    Resuscitation; 2000 Aug; 45(3):S3-6. PubMed ID: 10959027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.